Prudential Financial
MCRB icon

Prudential Financial’s Seres Therapeutics MCRB Stock Holding History

Prudential Financial’s Portfolio MCRB Stock Details MCRB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-2,174
Closed -$41.1K – 2545
2024
Q3 		$41.1K Sell
2,174
-230
-10% -$4.67K ﹤0.01% 2663
2024
Q2 		$34.8K Buy
2,404
+1,267
+111% +$21.1K ﹤0.01% 2649
2024
Q1 		$17.6K Buy
+1,137
New +$24.5K ﹤0.01% 2649
2023
Q3 		– Sell
-10,307
Closed -$987K – 2659
2023
Q2 		$987K Buy
+10,307
New +$1.12M ﹤0.01% 1816
2023
Q1 		– Sell
-6,973
Closed -$781K – 2643
2022
Q4 		$781K Sell
6,973
-50
-0.7% -$6.7K ﹤0.01% 1825
2022
Q3 		$901K Buy
7,023
+5,045
+255% +$517K ﹤0.01% 1807
2022
Q2 		$136K Buy
+1,978
New +$170K ﹤0.01% 2503

Other funds holding MCRB

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Vontobel Holding
Vontobel Holding Zurich, Switzerland $29.1B AUM 22.79% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Prudential Financial's MCRB Position: Q4 2024 in Review

Prudential Financial sold out of Seres Therapeutics (MCRB) in Q4 2024, closing a stake of 2,174 shares — an estimated $41.1K sold.

Prudential Financial first reported a position in MCRB in Q2 2022 and held it in 7 quarters. The position peaked at $987K in Q2 2023. 69 funds tracked by Wall St. Rank hold MCRB as of Q4 2024.

  • Prudential Financial reported no remaining Seres Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Prudential Financial sold 2,174 Seres Therapeutics shares in Q4 2024, an estimated $41.1K.
  • Prudential Financial first reported a position in Seres Therapeutics in Q2 2022 and held it in 7 quarters.
  • Prudential Financial's Seres Therapeutics position peaked at $987K in Q2 2023.
  • 69 funds tracked by Wall St. Rank held Seres Therapeutics as of Q4 2024.

Based on Prudential Financial's 13F filing for Q4 2024, filed 11 Feb 2025.